Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - CHANGE IN WORKING CAPITAL
Change in Working Capital PRPH - ProPhase Labs, Inc.
-5.7 M
LAST VALUE
53.97%
2 YEAR CAGR
-27.42%
5 YEAR CAGR
-38.98%
10 YEAR CAGR